Dr. Jorge E. Salazar, MD

Dr. Salazar practices at Health First Medical Group in Rockledge, Florida.

Dr. Salazar's NPI, 1225012867, was assigned on December 6, 2005. Dr. Salazar graduated from University of Miami, Miller School of Medicine in 1987. Dr. Salazar holds Florida license ME56809.

Dr. Salazar's primary practice is Health First Medical Group, at 3300 S Fiske Blvd, Rockledge, FL 32955 in Brevard County. The practice phone is (321) 434-5055.

Dr. Salazar's primary practice is Health First Medical Group in Rockledge, Florida. Dr. Salazar is also affiliated with Holmes Regional Medical Center. The medical group on file is Health First Medical Group (Formerly Mima). Dmand AI also links Dr. Salazar to 2 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Salazar practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Salazar's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Salazar is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Salazar's licenses on file in 2 states: Florida and North Carolina.

Dmand AI lists acid reflux, acute mini-stroke (TIA), acute sinusitis, acute skin infection, alzheimer's disease, aneurysm, ankle or foot injury and anxiety among the conditions Dr. Salazar treats.

CMS data shows 3,269 Medicare services from Dr. Salazar across 11 procedure codes in 2024, for 861 Medicare patients. Medicare paid $163,009 for them. Every service was in an office.

CMS counts 861 Medicare patients who saw Dr. Salazar in 2024. The largest group is 65 to 74, with 441 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Salazar's median patient age at 76, with 71% women.

In 2024, Dr. Salazar wrote 7,277 Medicare Part D claims for 444 patients. 88% of them were for generic drugs. CMS names the drug for 6,561 of them, across 121 drugs with 11 or more claims each, at $634,240 in total drug cost. In 2023, CMS named 6,795 claims across 127 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Salazar for performance year 2024, reported through an alternative payment model (APM). Dr. Salazar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Salazar as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 63 general payments to Dr. Salazar from 18 drug and device companies from 2016 to 2025. Device or supply loans make up the largest share, 54% of the total. AngioDynamics, Inc. paid the most, $5,033. It also lists 1 research payment totaling $1,000 in 2017.

Dmand AI lists 4 awards for Dr. Salazar, most recently NCQA DRP in 2015.

Dr. Salazar graduated from University of Miami, Miller School of Medicine in 1987.

Dr. Salazar is in network with 8 carriers, including Elevance, United Healthcare and Alliant Health Plans. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.